Dr. Lisa Nash, a TCOM graduate, will continue to lead the college toward excellence. Leadership at The University of North ...

Preston-based clinical trials group, Panthera, has signed two clinical trial contracts worth more than £10m each. These ...

Researchers identify the Asah1 gene as a promising target for novel therapies to treat nonalcoholic fatty liver disease ...

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic fatty liver diseases (NAFLD) into more severe forms of liver disease by ...

Panthera, the UK’s largest SMO (Site Management Organisation), has recently signed two clinical trial contracts worth over £10 million each. These trials for international pharma companies involve ...

How to Stop Controlling Others and Start Caring for Yourself,” a guide to shedding toxic relationships, has sold more than ...

Surgical Fat Reduction Caliway's CBL-514 Phase 2 study (CBL-0202) has been accepted for publication in Aesthetic Surgery Journal (ASJ), the top-ranked journal in aesthetic medicine and plastic surgery ...

AFL great Luke Hodge has put Isaac Heeney on notice, pinpointing a number of questionable efforts in the Swans' loss to ...

What I didn’t realize until after the procedure was how much clarity I had lost. Less than 24 hours later, the world looks brighter than ever.

PatientIQ is proud to announce the launch of DataPRO, a groundbreaking market intelligence tool built on real-world data. Designed to empower healthcare professionals with actionable insights derived ...

Non-Alcoholic Fatty Liver Disease (NAFLD) is emerging as a significant global health concern, driven by increasing rates of obesity, diabetes and sedentary lifestyles. NAFLD includes a spectrum of ...